Ocugen (OCGN) Revenue (2014 - 2026)

Ocugen (OCGN) posted Revenue of $1.5 million for Q1 2026, up 894.3% on a QoQ basis from -$193000.0 in Q4 2025, and up 3.51% year-over-year from $1.5 million in Q1 2025.

Ocugen (OCGN) Revenue (2014 - 2026) Analysis & Trends

Ocugen's Revenue history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

  • Quarterly Revenue rose 3.51% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 1.26% YoY) and the FY2025 annual result came in at $4.4 million, up 8.83% from the prior year.
  • Revenue was $1.5 million for Q1 2026 at Ocugen, up from -$193000.0 in the prior quarter.
  • Across five years, Revenue topped out at $3.7 million in Q3 2023 and bottomed at -$193000.0 in Q4 2025.
  • A 5-year average of $1.1 million and a median of $1.0 million in 2024 frame the typical range for Revenue.
  • Annual changes were most pronounced in 2023 — Revenue surged 693.78% — and 2025, when it tumbled 125.26%.
  • Ocugen's Revenue stood at $879000.0 in 2022, then surged by 60.3% to $1.4 million in 2023, then slumped by 45.78% to $764000.0 in 2024, then tumbled by 125.26% to -$193000.0 in 2025, then soared by 894.3% to $1.5 million in 2026.
  • Business Quant data shows OCGN's Revenue at $1.5 million in Q1 2026, -$193000.0 in Q4 2025, and $1.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ocugen 63.79 Mn 63.79 Mn - 1.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.53 Mn
Dec 31, 2025 -193,000.00
Sep 30, 2025 1.75 Mn
Jun 30, 2025 1.37 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 764,000.00
Sep 30, 2024 1.14 Mn
Jun 30, 2024 1.14 Mn
Mar 31, 2024 1.01 Mn
Dec 31, 2023 1.41 Mn
Sep 30, 2023 3.70 Mn
Jun 30, 2023 485,000.00
Mar 31, 2023 443,000.00
Dec 31, 2022 879,000.00
Sep 30, 2022 466,000.00
Jun 30, 2022 643,000.00
Mar 31, 2022 500,000.00
Jun 30, 2020 43,000.00
Sep 30, 2014 300.00 Mn